Personalized medicine Leverage Interpace's focus on molecular diagnostics, pharmacogenomics, and bioinformatics to position end-to-end personalized medicine solutions for pharma partners seeking stratified patient cohorts and more targeted clinical trial designs.

Diagnostics expansion Target opportunities around Interpace Diagnostics Pleural Biopsy System and Barrett's Esophagus tests to expand product adoption in thoracic and GI oncology spaces, aligning with hospital systems pursuing noninvasive or minimally invasive diagnostic workflows.

Pharma collaborations Engage with Interpace Pharma Solutions for pharmacogenomics, genotyping, and biorepository services to support pharma and biotech clients in drug development, stratified trial enrollment, and safer, faster regulatory approvals.

Clinical validation leverage Highlight the company’s ongoing clinical validation efforts for thyroid cancer and other molecular tests as a credibility pillar to win partnerships with KOLs, academic centers, and contract research organizations seeking validated diagnostic platforms.

Strategic partnerships Position collaboration opportunities with Twist Bioscience and other tech/biotech partners to co-develop translational studies and clinical trial solutions, expanding capabilities in synthetic biology, miRNA/risk classifiers, and related biomarker programs.